Exchange: NASDAQ·Updated 07:57 PM EST

KOD News

News
all
press releases
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
KOD reports a wider-than-expected Q3 loss, while positive phase III results for Zenkuda and pipeline progress fuel its upcoming regulatory plans.
Zacks
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
KOD reports a wider-than-expected Q3 loss, while positive phase III results for Zenkuda and pipeline progress fuel its upcoming regulatory plans.
Zacks
More News
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial ResultsPR NewswirePALO ALTO, Calif., Nov. 12, 2026 PALO ALTO, Calif., Nov. 12, 2026 /PRNewswire/ -- Kodiak Sciences...
PR Newswire
Kodiak Sciences to Present at Three Upcoming Investor Conferences Kodiak Sciences to Present at Three Upcoming Investor ConferencesPR NewswirePALO ALTO, Calif., Nov. 11, 2026 PALO ALTO, Calif., Nov. 11, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused...
PR Newswire
Kodiak's Zenkuda shows promise across three retinal diseases, with positive phase III data and a planned 2026 regulatory filing.
Zacks
Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026 Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026PR NewswirePALO ALTO, Calif., Oct. 7, 2026First scientific presentation of Phase 3 DAYBREAK results for Zenkuda and...
PR Newswire
Three healthcare stocksQuantum-Si, Kodiak Sciences and Iovanceshow overbought RSI readings above 80, warning momentum-focused investors.read more...
Benzinga
OCUL stock selloff began on Monday after Kodiak Sciences and 4D Molecular posted updates from clinical trials of their eye-disease drugs.
Stocktwits
Kodiak surges 178% as positive phase III DAYBREAK data show Zenkuda and tabirafusp-ted met key endpoints against Eylea.
Zacks
On Stocktwits, retail sentiment toward SPY and QQQ stayed ‘bullish.’
Stocktwits
Shares of Kodiak Sciences, Repligen, and Biogen surged to annual highs amid positive company catalysts.
Stocktwits

Advertisement|Remove ads.